biosimilars

Viewpoint: Embracing biosimilars will drive down prices, increase access to drugs

Sean McGowan | 
The biosimilar category holds incredible promise, and the market for these products is on an upward trajectory. But it’s been ...
3-26-2019 gaining momentum on the road to accessible biosimilars

Viewpoint: We need to speed up biosimilar drug approval process

Carlos Sattler, Sheila Frame | 
Generic versions of brand-name small-molecule drugs saved Americans more than $1 trillion between 1999 and 2010. Biosimilars now have the potential ...
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists